Page last updated: 2024-10-24

cadralazine and Left Ventricular Hypertrophy

cadralazine has been researched along with Left Ventricular Hypertrophy in 2 studies

cadralazine: structure given in first source

Research Excerpts

ExcerptRelevanceReference
"This study compared the effects of 1 year of monotherapy with a calcium-channel antagonist (nilvadipine; NIL), an angiotensin-converting enzyme (ACE) inhibitor (temocapril; TEM), or a new vasodilator (cadralazine; CAD) on left ventricular (LV) hypertrophy in essential hypertension."5.08The effects of long-term treatment on left ventricular hypertrophy in patients with essential hypertension: relation to changes in neurohumoral factors. ( Inoue, H; Oh-hashi, S; Takata, M; Tomita, S; Ueno, H; Yasumoto, K, 1997)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ueno, H2
Takata, M2
Tomita, S2
Oh-hashi, S1
Yasumoto, K2
Inoue, H2
Tomoda, F1

Trials

2 trials available for cadralazine and Left Ventricular Hypertrophy

ArticleYear
The effects of long-term treatment on left ventricular hypertrophy in patients with essential hypertension: relation to changes in neurohumoral factors.
    Journal of cardiovascular pharmacology, 1997, Volume: 30, Issue:5

    Topics: Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial

1997
Different effects of temocapril and cadralazine on electrocardiographic voltages and left ventricular mass in patients with essential hypertension.
    Japanese heart journal, 1999, Volume: 40, Issue:1

    Topics: Aged; Antihypertensive Agents; Echocardiography; Electrocardiography; Female; Humans; Hypertension;

1999